Assessment of Finite and Infinite Dose In Vitro Experiments in Transdermal Drug Delivery

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2021 Apr 3

PMID 33801998

Citations 5

Authors

Luisa Coderch

Ilaria Collini

Victor Carrer

Clara Barba

Cristina Alonso

Affiliations

Soon will be listed here.

Abstract

Penetration, usually with finite dosing, provides data about the total active amount in the skin and permeation, being the most used methodology, usually with infinite dosing, leads to data about pharmacokinetic parameters. The main objective of this work is to assess if results from permeation, most of them at finite dose, may be equivalent to those from penetration usually at infinite dose. The transdermal behavior of four drugs with different physicochemical properties (diclofenac sodium, ibuprofen, lidocaine, and caffeine) was studied using penetration/finite and kinetic permeation/infinite dose systems using vertical Franz diffusion cells to determine the relationships between permeation and penetration profiles. Good correlation of these two in vitro assays is difficult to find; the influence of their dosage and the proportion of different ionized/unionized compounds due to the pH of the skin layers was demonstrated. Finite and infinite dose regimens have different applications in transdermal delivery. Each approach presents its own advantages and challenges. Pharmaceutical industries are not always clear about the method and the dose to use to determine transdermal drug delivery. Being aware that this study presents results for four actives with different physicochemical properties, it can be concluded that the permeation/infinite results could not be always extrapolated to those of penetration/finite. Differences in hydrophilicity and ionization of drugs can significantly influence the lack of equivalence between the two methodologies. Further investigations in this field are still needed to study the correlation of the two methodologies and the main properties of the drugs that should be taken into account.

Citing Articles

Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations.

Lunter D, Klang V, Eichner A, Savic S, Savic S, Lian G Pharmaceutics. 2024; 16(6).

PMID: 38931938 PMC: 11207871. DOI: 10.3390/pharmaceutics16060817.

Non-invasive evaluation of transdermal drug delivery using 3-D transient triplet differential (TTD) photoacoustic imaging.

Xie Y, Wu H, Chen Z, Sun Q, Liu X, Jiang J Photoacoustics. 2023; 32:100530.

PMID: 37645257 PMC: 10461203. DOI: 10.1016/j.pacs.2023.100530.

Preparation, Characterization and Permeation Study of Topical Gel Loaded with Transfersomes Containing Asiatic Acid.

Opatha S, Titapiwatanakun V, Boonpisutiinant K, Chutoprapat R Molecules. 2022; 27(15).

PMID: 35956816 PMC: 9369753. DOI: 10.3390/molecules27154865.

Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer.

Vora D, Dandekar A, Bhattaccharjee S, Singh O, Agrahari V, Peet M Pharmaceutics. 2022; 14(3).

PMID: 35336054 PMC: 8953220. DOI: 10.3390/pharmaceutics14030680.

Synergistic Effect of Chemical Penetration Enhancers on Lidocaine Permeability Revealed by Coarse-Grained Molecular Dynamics Simulations.

Bozdaganyan M, Orekhov P Membranes (Basel). 2021; 11(6).

PMID: 34072597 PMC: 8227207. DOI: 10.3390/membranes11060410.

References

Gregoire S, Ribaud C, Benech F, Meunier J, Garrigues-Mazert A, Guy R . Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations. Br J Dermatol. 2008; 160(1):80-91. DOI: 10.1111/j.1365-2133.2008.08866.x. View

Hashida M, Okamoto H, Sezaki H . Analysis of drug penetration through skin considering donor concentration decrease. J Pharmacobiodyn. 1988; 11(9):636-44. DOI: 10.1248/bpb1978.11.636. View

Franz T, Lehman P, Franz S, Demetrulias J, Kelling C, Moloney S . Percutaneous penetration of N-nitrosodiethanolamine through human skin (in vitro): comparison of finite and infinite dose applications from cosmetic vehicles. Fundam Appl Toxicol. 1993; 21(2):213-21. DOI: 10.1006/faat.1993.1091. View

Lian G, Chen L, Han L . An evaluation of mathematical models for predicting skin permeability. J Pharm Sci. 2007; 97(1):584-98. DOI: 10.1002/jps.21074. View

Potts R, Guy R . Predicting skin permeability. Pharm Res. 1992; 9(5):663-9. DOI: 10.1023/a:1015810312465. View

Sugibayashi K, Todo H, Oshizaka T, Owada Y . Mathematical model to predict skin concentration of drugs: toward utilization of silicone membrane to predict skin concentration of drugs as an animal testing alternative. Pharm Res. 2009; 27(1):134-42. DOI: 10.1007/s11095-009-9987-y. View

Wiechers J, Watkinson A, Cross S, Roberts M . Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery. Int J Cosmet Sci. 2012; 34(6):525-35. DOI: 10.1111/ics.12001. View

Godin B, Touitou E . Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007; 59(11):1152-61. DOI: 10.1016/j.addr.2007.07.004. View

Briggaman R, WHEELER Jr C . The epidermal-dermal junction. J Invest Dermatol. 1975; 65(1):71-84. DOI: 10.1111/1523-1747.ep12598050. View

10.

Zsiko S, Cutcher K, Kovacs A, Budai-Szucs M, Gacsi A, Baki G . Nanostructured Lipid Carrier Gel for the Dermal Application of Lidocaine: Comparison of Skin Penetration Testing Methods. Pharmaceutics. 2019; 11(7). PMC: 6681122. DOI: 10.3390/pharmaceutics11070310. View

11.

Schmid-Wendtner M, Korting H . The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006; 19(6):296-302. DOI: 10.1159/000094670. View

12.

Bartosova L, Bajgar J . Transdermal drug delivery in vitro using diffusion cells. Curr Med Chem. 2012; 19(27):4671-7. DOI: 10.2174/092986712803306358. View

13.

Buist H, van Burgsteden J, Freidig A, Maas W, van de Sandt J . New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010; 57(2-3):200-9. DOI: 10.1016/j.yrtph.2010.02.008. View

14.

Frasch H, Barbero A . The transient dermal exposure: theory and experimental examples using skin and silicone membranes. J Pharm Sci. 2007; 97(4):1578-92. DOI: 10.1002/jps.21035. View

15.

Alonso C, Carrer V, Espinosa S, Zanuy M, Cordoba M, Vidal B . Prediction of the skin permeability of topical drugs using in silico and in vitro models. Eur J Pharm Sci. 2019; 136:104945. DOI: 10.1016/j.ejps.2019.05.023. View

16.

Chi C, Lee M, Weng C, Leong M . In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach. Int J Mol Sci. 2019; 20(13). PMC: 6651837. DOI: 10.3390/ijms20133170. View

17.

Wagner H, Kostka K, Lehr C, Schaefer U . Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents. J Control Release. 2001; 75(3):283-95. DOI: 10.1016/s0168-3659(01)00396-0. View

18.

Zhang Y, Lane M, Hadgraft J, Heinrich M, Chen T, Lian G . A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model. Int J Pharm. 2018; 556:142-149. DOI: 10.1016/j.ijpharm.2018.11.065. View

19.

Neupane R, Boddu S, Renukuntla J, Jayachandra Babu R, Tiwari A . Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities. Pharmaceutics. 2020; 12(2). PMC: 7076422. DOI: 10.3390/pharmaceutics12020152. View

20.

Arce Jr F, Asano N, See G, Oshizaka T, Itakura S, Todo H . Prediction of skin permeation and concentration of rhododendrol applied as finite dose from complex cosmetic vehicles. Int J Pharm. 2020; 578:119186. DOI: 10.1016/j.ijpharm.2020.119186. View